Cargando…

Science review: Genetic variability in the systemic inflammatory response

The present review discusses recent studies that have identified genetic differences in inflammatory proteins associated with different phenotypic presentations of systemic inflammation. Basic genetic terminology is defined. Implications of genetic influences on the inflammatory response are discuss...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waterer, Grant W, Wunderink, Richard G
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC270696/ https://www.ncbi.nlm.nih.gov/pubmed/12930554 http://dx.doi.org/10.1186/cc2164

Ejemplares similares

COVID-19: First Do No Harm
por: Waterer, Grant W., et al.
Publicado: (2020)

Antibiotic‐resistant bacteria: COVID‐19 hasn't made the challenge go away
por: Waterer, Grant, et al.
Publicado: (2021)

Adjunctive and Supportive Measures for Community-Acquired Pneumonia
por: Waterer, G. W., et al.
Publicado: (2010)

The Genetics of Sepsis: The Promise, the Progress and the Pitfalls
por: Waterer, Grant W.
Publicado: (2008)

Lack of Association of the Caspase-12 Long Allele with Community-Acquired Pneumonia in People of African Descent
por: Chen, Jiwang, et al.
Publicado: (2014)

What is pneumonia?
por: Waterer, Grant
Publicado: (2021)

Advances in anti-fungal therapies
por: Waterer, Grant
Publicado: (2021)

Advances in community-acquired pneumonia
por: Jones, Barbara, et al.
Publicado: (2020)

Beyond antibiotics: recent developments in the diagnosis and management of nontuberculous mycobacterial infection
por: Gleeson, Laura E., et al.
Publicado: (2022)

Diagnosing Viral and Atypical Pathogens in the Setting of Community-Acquired Pneumonia
por: Waterer, Grant W.
Publicado: (2017)

Understanding COVID-19 Pathophysiology: What Defines Progress?
por: Waterer, Grant
Publicado: (2021)

Breathing Hope into Directed Therapy for Pulmonary Infections
por: Waterer, Grant
Publicado: (2021)

Choosing the right combination therapy in severe community-acquired pneumonia
por: Waterer, Grant W, et al.
Publicado: (2006)

Steroids and COVID-19: We Need a Precision Approach, Not One Size Fits All
por: Waterer, Grant W., et al.
Publicado: (2020)

Impact of Genetic Variability on Physiological Responses to Caffeine in Humans: A Systematic Review
por: Fulton, Jacob L., et al.
Publicado: (2018)

Hot topics and current controversies in community-acquired pneumonia
por: Severiche-Bueno, Diego, et al.
Publicado: (2019)

The need for translational research in respiratory medicine
por: Lee, YC Gary, et al.
Publicado: (2013)

Reply to Chahine, to Schuetz, and to Fabre et al.
por: Metlay, Joshua P., et al.
Publicado: (2020)

Reply to Huttner et al.: 2019 Community-acquired Pneumonia Treatment Guidelines: There Is a Need for a Change toward More Parsimonious Antibiotic Use
por: Metlay, Joshua P., et al.
Publicado: (2020)

Can Electronic Decision Support Tools Really Reduce Mortality from Community-acquired Pneumonia?
por: Waterer, Grant, et al.
Publicado: (2022)

Serological response to influenza vaccination among adults hospitalized with community‐acquired pneumonia
por: Pratt, Caroline Quinn, et al.
Publicado: (2018)

Cytokines in the systemic inflammatory response syndrome: a review
por: Jaffer, U, et al.
Publicado: (2010)

Post-COVID Care: Untying the Covidian Knot
por: Goeminne, Pieter C., et al.
Publicado: (2022)

Treatment of Gram-negative pneumonia in the critical care setting: is the beta-lactam antibiotic backbone broken beyond repair?
por: Bassetti, Matteo, et al.
Publicado: (2016)

Interstitial lung disease before and after COVID-19: a double threat?
por: Valenzuela, Claudia, et al.
Publicado: (2021)

Community-Acquired Pneumonia Visualized on CT Scans but Not Chest Radiographs: Pathogens, Severity, and Clinical Outcomes
por: Upchurch, Cameron P., et al.
Publicado: (2018)

COVID-19, steroids and other immunomodulators: The jigsaw is not complete
por: Rello, Jordi, et al.
Publicado: (2020)

Chromothripsis—Explosion in Genetic Science
por: Shorokhova, Mariia, et al.
Publicado: (2021)

Variability of the drug response to nonsteroidal anti-inflammatory drugs according to cyclooxygenase-2 genetic polymorphism
por: Lee, Sook Joung, et al.
Publicado: (2017)

Procalcitonin as a marker of the systemic inflammatory response to infection
por: Reinhart, K., et al.
Publicado: (2014)

Personalizing antipsychotic treatment: evidence and thoughts on individualized tailoring of antipsychotic dosage in the treatment of psychotic disorders
por: Wunderink, Lex
Publicado: (2019)

The pediatric common variable immunodeficiency — from genetics to therapy: a review
por: Szczawinska-Poplonyk, Aleksandra, et al.
Publicado: (2021)

Science Review: Vasopressin and the cardiovascular system part 1 – receptor physiology
por: Holmes, Cheryl L, et al.
Publicado: (2003)

Science Review: Vasopressin and the cardiovascular system part 2 – clinical physiology
por: Holmes, Cheryl L, et al.
Publicado: (2004)

Serotonin, genetic variability, behaviour, and psychiatric disorders - a review
por: Nordquist, Niklas, et al.
Publicado: (2010)

Safety of SABA Monotherapy in Asthma Management: a Systematic Review and Meta-analysis
por: Sriprasart, Thitiwat, et al.
Publicado: (2022)

Variability in the Analgesic Response to Ibuprofen Is Associated With Cyclooxygenase Activation in Inflammatory Pain
por: Theken, Katherine N., et al.
Publicado: (2019)

Role of genetic polymorphisms in clopidogrel response variability: a systematic review
por: Lopez, Jose, et al.
Publicado: (2023)

Exploring the Role of Genetic Variability and Lifestyle in Oxidative Stress Response for Healthy Aging and Longevity
por: Dato, Serena, et al.
Publicado: (2013)

Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia
por: Self, Wesley H., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fmjivca7v0ln9hgfcmmuk9sj4m